DestiNA Genomics
Pre-clinicalEnable routine miRNA use in drug development with Destina’s PCR-free technology. Single-well multi-omic assays ensuring data integrity for FDA/EMA submissions.
Founded
2011
Focus
Genetics & Genomics
About
Enable routine miRNA use in drug development with Destina’s PCR-free technology. Single-well multi-omic assays ensuring data integrity for FDA/EMA submissions.
Funding History
3Total raised: $7.5M
Series A$5.2MMercia Fund ManagersOct 15, 2017
Grant$800KInnovate UKMar 15, 2015
Seed$1.5MScottish Investment BankMay 15, 2013
Company Info
TypePrivate
Founded2011
LocationEdinburgh, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile